Online citations, reference lists, and bibliographies.
← Back to Search

Combination Of Bevacizumab And 2-weekly Pegylated Liposomal Doxorubicin As First-line Therapy For Locally Recurrent Or Metastatic Breast Cancer. A Multicenter, Single-arm Phase II Trial (SAKK 24/06)

C. Rochlitz, T. Ruhstaller, S. Lerch, C. Spirig, J. Huober, T. Suter, M. Bühlmann, M. Fehr, A. Schönenberger, R. von Moos, R. Winterhalder, D. Rauch, A. Müller, M. Mannhart-Harms, R. Herrmann, B. Cliffe, M. Mayer, K. Zaman

Cite This
Download PDF
Analyze on Scholarcy
Share